- $335.54m
- $349.24m
- $508.57m
- 95
- 80
- 99
- 100
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.87 | ||
| PEG Ratio (f) | 0.6 | ||
| EPS Growth (f) | 17.39% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.08 | ||
| Price to Tang. Book | 3.46 | ||
| Price to Free Cashflow | 12.96 | ||
| Price to Sales | 0.64 | ||
| EV to EBITDA | 5.52 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 27.91% | ||
| Return on Equity | 27.88% | ||
| Operating Margin | 8.66% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 405.13 | 443.39 | 492.85 | 523.12 | 508.57 | 530.85 | 553.65 | 6.66% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +670.52 | +8.23 | +40.12 | +11.99 | +28.07 | +15.81 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
IBEX Limited is a provider of global business process outsourcing and end-to-end customer engagement technology solutions. The Company helps brands effectively engage their customers with services ranging from customer support, technical support, inbound/outbound sales, business intelligence and analytics, digital demand generation, and customer experience (CX) surveys and feedback analytics. Through the Company’s integrated customer lifecycle experience (CLX) platform, a comprehensive portfolio of solutions is offered to help optimize customer acquisition, engagement, expansion and experience for clients. The Company leverages advanced technology and proprietary analytics, in combination with its global footprint and business process outsourcing expertise, to protect and enhance clients’ brands. Its services cover three areas: Digital & Omni-Channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX).
Directors
- Mohammed Khaishgi CHM (54)
- Robert Dechant CEO (59)
- Karl Gabel CFO (57)
- Jeffrey Cox CEX (52)
- David Afdahl COO (47)
- Daniel Bellehsen EVP (35)
- Christy O'Connor GCN (52)
- Julie Casteel OTH (60)
- Bruce Dawson OTH (57)
- Shuja Keen DRC (45)
- Daniella Ballou-Aares IND (46)
- Fiona Beck IND (56)
- John Jones IND (66)
- Gerard Kleisterlee IND (75)
- John Leone IND (48)
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 28th, 2017
- Public Since
- August 7th, 2020
- No. of Shareholders
- 139
- No. of Employees
- 30,000
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Global Market- Shares in Issue
- 13,191,924
- Address
- 1717 Pennsylvania Avenue Nw, Suite 825, WASHINGTON, 20006
- Web
- https://www.ibex.co/
- Phone
- +1 2025806200
- Contact
- Michael Darwal
- Auditors
- Deloitte & Touche LLP
Upcoming Events for IBEX
Q3 2025 Ibex Ltd Earnings Call
Q4 2025 Ibex Ltd Earnings Release
Similar to IBEX
1stdibs.com
NASDAQ Global Market
Airship AI Holdings
NASDAQ Global Market
Alpha Modus Holdings
NASDAQ Global Market
AppFolio
NASDAQ Global Market
Appian
NASDAQ Global Market
FAQ
What is the IBEX share price?
As of Today at 21:13 UTC, shares in IBEX are trading at $25.44. This share price information is delayed by 15 minutes.
How has the IBEX share price performed this year?
Shares in IBEX last closed at $25.44 and the price had moved by +89.96% over the past 365 days. In terms of relative price strength the IBEX share price has outperformed the S&P500 Index by +71.29% over the past year.
What are the analyst and broker recommendations for IBEX?
The overall consensus recommendation for IBEX is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the IBEX dividend yield?
IBEX does not currently pay a dividend.
Does IBEX pay a dividend?
IBEX does not currently pay a dividend.
When does IBEX next pay dividends?
IBEX does not currently pay a dividend.
How do I buy IBEX shares?
To buy shares in IBEX you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of IBEX?
As of the previous close price of $25.44, shares in IBEX had a market capitalisation of $335.54m.
Where are IBEX shares listed?
Here are the trading details for IBEX:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: IBEX
What kind of share is IBEX?
Based on an overall assessment of its quality, value and momentum IBEX is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a IBEX share price forecast for 2025?
The analyst consensus target price for shares in IBEX is $26.00. That is 2.22% above the last closing price of $25.44.
Analysts covering IBEX currently have a consensus Earnings Per Share (EPS) forecast of $2.53 for the next financial year.
Find out moreWhat is the trend in the IBEX share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like IBEX. Over the past six months, its share price has outperformed the S&P500 Index by +40.93%.
As of the last closing price of $25.44, shares in IBEX were trading +22.04% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the IBEX PE Ratio?
The IBEX PE ratio based on its reported earnings over the past 12 months is 8.87. The shares last closed at $25.44.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of IBEX?
IBEX's management team is headed by:
- Mohammed Khaishgi - CHM
- Robert Dechant - CEO
- Karl Gabel - CFO
- Jeffrey Cox - CEX
- David Afdahl - COO
- Daniel Bellehsen - EVP
- Christy O'Connor - GCN
- Julie Casteel - OTH
- Bruce Dawson - OTH
- Shuja Keen - DRC
- Daniella Ballou-Aares - IND
- Fiona Beck - IND
- John Jones - IND
- Gerard Kleisterlee - IND
- John Leone - IND